share_log

Piper Sandler:重申NovoCure(NVCR.US)评级,由增持调整至增持评级, 目标价由25.00美元调整至28.00美元。

Zhitong Finance ·  Apr 10 09:05

Piper Sandler:重申NovoCure(NVCR.US)评级,由增持调整至增持评级, 目标价由25.00美元调整至28.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment